Schwann Cells in Charcot-Marie-Tooth Disease
Introduction <table class="infobox infobox-cell">Category </td>Location </td>Cell Type </td>Associated Disease </td>Inheritance </td>
Schwann Cells In Charcot Marie Tooth Disease is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Schwann cells are the principal glial cells of the peripheral nervous system, providing myelination, trophic support, and metabolic maintenance for axons. Charcot-Marie-Tooth disease (CMT) represents the most common inherited peripheral neuropathy, with the majority of forms resulting from mutations affecting Schwann cell function. Understanding Schwann cell pathology in CMT provides critical insights into disease mechanisms and therapeutic strategies. [@schwann2022]
Overview
Schwann Cell Biology ...
Schwann Cells in Charcot-Marie-Tooth Disease
Introduction <table class="infobox infobox-cell">Category </td>Location </td>Cell Type </td>Associated Disease </td>Inheritance </td>
Schwann Cells In Charcot Marie Tooth Disease is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Schwann cells are the principal glial cells of the peripheral nervous system, providing myelination, trophic support, and metabolic maintenance for axons. Charcot-Marie-Tooth disease (CMT) represents the most common inherited peripheral neuropathy, with the majority of forms resulting from mutations affecting Schwann cell function. Understanding Schwann cell pathology in CMT provides critical insights into disease mechanisms and therapeutic strategies. [@schwann2022]
Overview
Schwann Cell Biology
Types of Schwann Cells
Myelinating Schwann cells (mSCs) : Wrap large-diameter axons (>1μm)Remak Schwann cells (non-myelinating) : Remak bundles of small axonsTerminal Schwann cells : At neuromuscular junctionsSatellite glial cells : Surround neuronal cell bodies in gangliaMyelin Structure
Internode : Compact myelin segmentsNode of Ranvier : Unmyelinated gaps between internodes Schmidt-Lanterman incisures : Cytoplasmic channelsParanodal loops : Axoglial junctionsMolecular Components
Myelin proteins : PMP22, MPZ/P0, MBP, PLPNeuregulin-1 : Axonal signal for myelinationLGI1 : Leukocyte-gene-like 1, synaptic maintenanceConnexins : Gap junction proteins (Cx32, Cx29)Charcot-Marie-Tooth Disease
Classification CMT encompasses a heterogeneous group of peripheral neuropathies:
CMT1 (Demyelinating)
CMT1A: PMP22 duplication (most common)
CMT1B: MPZ/P0 mutations
CMT1X: GJB1 (Cx32) mutations
CMT1F: NB1/NGF mutations
CMT2 (Axonal)
CMT2A: MFN2 mutations
CMT2B: RAB7 mutations
CMT2K: GDAP1 mutations
CMT4 (Autosomal Recessive Demyelinating)
CMT4A: GDAP1 mutations
CMT4B1/B2: MTMR2, SBF2 mutations
CMT4C: SH3TC2 mutations
CMT Intermediate
DNM2 mutations
YARS mutations
Pathogenic Mechanisms
Myelin Assembly Defects
PMP22 duplication : Overexpression causes myelin instabilityMPZ mutations : Abnormal myelin protein zero assemblyGJB1 mutations : Gap junction dysfunctionAbnormal compaction : Disrupted myelin structureDemyelination
Segmental demyelination : Focal myelin breakdownOnion bulb formation : Redundant Schwann cell processesMyelin thinning : HypomyelinationDemyelination-remyelination cycles : Repeated cycles lead to onion bulbsAxonal Degeneration
Secondary axonal loss : Results from demyelinationPrimary axonal involvement : In CMT2Wallerian degeneration : Distal axonal degenerationSlow progression : Gradual nerve fiber lossSchwann Cell Dysfunction
[Autophagy](/entities/autophagy) defects : Accumulation of abnormal proteinsMitochondrial dysfunction : Energy impairmentEndoplasmic reticulum stress : [Unfolded protein response](/entities/unfolded-protein-response)Impaired dedifferentiation : Failure to support regenerationNeurodegeneration in CMT
Mechanisms of Neuronal Death
Chronic demyelination : Leads to axonal degenerationTrophic factor deprivation : Impaired axonal supportCalcium dysregulation : ExcitotoxicityOxidative stress : Free radical damageDistal Axonopathy
Length-dependent degeneration : "dying-back" neuropathyDistal-to-proximal progression : Early distal involvementDenervation : Muscle fiber lossImplications for CNS While CMT primarily affects peripheral nerves, recent studies suggest:
Central nervous system involvement : Some CMT subtypesCognitive function : Possible cognitive changesNeuroimaging findings : White matter changesTherapeutic Approaches
Gene Therapy
PMP22 reduction : Antisense oligonucleotidesGene replacement : For recessive formsGene editing : CRISPR-based approachesViral vectors : AAV-mediated deliverySmall Molecule Therapies
Neurotrophic factors : BDNF, GDNFAntioxidants : Vitamin E, alpha-lipoic acidAnti-inflammatory : CurcuminMyelin stabilizers : ClemastineCell-Based Therapies
Schwann cell transplantation : Peripheral nerve repairiPSC-derived Schwann cells : Autologous transplantationMesenchymal stem cells : Paracrine supportOlfactory ensheathing cells : Nerve regenerationRehabilitation
Physical therapy : Maintain muscle strengthOccupational therapy : Adaptive strategiesOrthopedic interventions : Prevent deformitiesAssistive devices : Mobility aidsAnimal Models
Spontaneous Mutants
Trembler mouse : PMP22 point mutationShambling mouse : Pmp22 deletionCnp1 knockout : Myelin maintenanceTransgenic Models
PMP22 transgenic : CMT1A modelMPZ knockout : CMT1B modelMFN2 mutants : CMT2A modelResearch Insights
Demyelination mechanisms : Pathway discoveriesTherapeutic testing : Drug screening platformsBiomarkers : Disease progression markersKey Publications
[Lupski & Reid, Charcot-Marie-Tooth disease (2010)](https://doi.org/10.1056/NEJMoa0907601)
[Scherer & Wrabetz, Molecular mechanisms of CMT (2008)](https://doi.org/10.1016/j.neuroscience.2008.03.059)
[Pareyson et al., CMT1A pathogenesis (2009)](https://doi.org/10.1001/archneurol.2009.203)
[Niemann et al., CMT4 subtypes (2006)](https://doi.org/10.1093/brain/awl102)
[Hattori & Yamamoto, Schwann cell therapy (2004)](https://doi.org/10.1016/j.neuroscience.2004.04.033)
[Kelley et al., CMT animal models (2014)](https://doi.org/10.1093/hmg/ddu278)
[Fledrich et al., Schwann cell pathology in CMT (2014)](https://doi.org/10.1093/brain/awu060)
[Sahenk & Reed, Gene therapy for CMT (2008)](https://doi.org/10.1089/hum.2008.124)
See Also
[Schwann Cells](/cell-types/schwann-cells)
[Myelin Biology](/mechanisms/myelin-maintenance)
[Peripheral Neuropathy](/diseases/peripheral-neuropathy)
[Charcot-Marie-Tooth Disease](/diseases/charcot-marie-tooth-disease)
[Axonal Degeneration](/mechanisms/axonal-degeneration)
[Neurotrophic Factors](/mechanisms/neurotrophic-factors)
[Neurogenetics](/mechanisms/neurogenetics)
[Peripheral Nerve Regeneration](/mechanisms/peripheral-nerve-regeneration)
Background The study of Schwann Cells In Charcot Marie Tooth Disease has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
Pathway Diagram
Mermaid diagram (expand to render)
Show full description